APO RESEARCH · REPORT
Medical Hyperspectral Imaging (MHSI)
Medical Hyperspectral Imaging (MHSI) can also support surgeons by offering them information that’s invisible to the naked eye – in real time. That medical hyperspectral image can be displayed on a screen. Or the hyperspectral information can be added as an overlay to the surgeon’s perspective by means of augmented reality glasses. This help surgeon to identify which anatomical structures to preserve when removing sick tissues.
Product & engineering
Understand the product.
Medical Hyperspectral Imaging (MHSI) can also support surgeons by offering them information that’s invisible to the naked eye – in real time. That medical hyperspectral image can be displayed on a screen. Or the hyperspectral information can be added as an overlay to the surgeon’s perspective by means of augmented reality glasses. This help surgeon to identify which anatomical structures to preserve when removing sick tissues.
Selected research
Industry Research
Medical Hyperspectral Imaging (MHSI) Industry Research Report 2026
Market perspective
Medical Hyperspectral Imaging (MHSI) can also support surgeons by offering them information that’s invisible to the naked eye – in real time. That medical hyperspectral image can be displayed on a screen. Or the hyperspectral information can be added as an overlay to the surgeon’s perspective by means of augmented reality glasses. This help surgeon to identify which anatomical structures to preserve when removing sick tissues.
Americas has the largest global export quantity and manufacturers in Medical Hyperspectral Imaging (MHSI) market with about 44% market share in 2019, while the APAC is the second sales volume market for about 35% of the market and the number is still increasing.
In the industry, Headwall Photonics profits most in 2019 and recent years, while Resonon and IMEC ranked 2 and 3. The market share of them is 24.38%, 17.44% and 10.82% in 2019.The gap of market share is keep on enlarged due to different strategy.
Read the full market overview
Nowadays, there are three mainly types of Medical Hyperspectral Imaging (MHSI), including Visible + Near Infrared Light, Short-Wavelength Infrared and Other. And Visible + Near Infrared Light is the main type for Medical Hyperspectral Imaging (MHSI), and the Visible + Near Infrared Light reached a sales value of approximately 66.14% of global sales value.
Hyperspectral Imaging has a wide range of applications, the major applications including Diagnostic Centres, Hospitals, Research & Academic Centres
and Pharmaceutical & Biotechnology Companies, Pharmaceutical & Biotechnology Companies is the most important part, as the market share is nearly 42%.
Report Scope
This report quantifies the global Medical Hyperspectral Imaging (MHSI) market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Medical Hyperspectral Imaging (MHSI) Market by Company
Headwall Photonics
Resonon
IMEC
EVK DI Kerschhaggl
Cubert
Galileo
Specim
Gooch & Housego
Surface Optics
Norsk Elektro Optikk A/S
Wayho Technology
BaySpec
Medical Hyperspectral Imaging (MHSI) Segment by Type
Visible + Near Infrared Light
Short-Wavelength Infrared
Others
Medical Hyperspectral Imaging (MHSI) Segment by Application
Diagnostic Centres
Hospitals
Research & Academic Centres
Pharmaceutical & Biotechnology Companies
Medical Hyperspectral Imaging (MHSI) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Hyperspectral Imaging (MHSI) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical Hyperspectral Imaging (MHSI) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Hyperspectral Imaging (MHSI).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Medical Hyperspectral Imaging (MHSI) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Medical Hyperspectral Imaging (MHSI) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Medical Hyperspectral Imaging (MHSI) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Visible + Near Infrared Light
- Short-Wavelength Infrared
- Others
Applications
- Diagnostic Centres
- Hospitals
- Research & Academic Centres
- Pharmaceutical & Biotechnology Companies
Companies covered
- Headwall Photonics
- Resonon
- IMEC
- EVK DI Kerschhaggl
- Cubert
- Galileo
- Specim
- Gooch & Housego
- Surface Optics
- Norsk Elektro Optikk A/S
- Wayho Technology
- BaySpec
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Medical Hyperspectral Imaging (MHSI) Market Size (2021-2032)
- 2.2.2 Global Medical Hyperspectral Imaging (MHSI) Sales (2021-2032)
- 2.2.3 Global Medical Hyperspectral Imaging (MHSI) Market Average Price (2021-2032)
- 2.3 Medical Hyperspectral Imaging (MHSI) by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Visible + Near Infrared Light
- 2.3.3 Short-Wavelength Infrared
- 2.3.4 Others
- 2.4 Medical Hyperspectral Imaging (MHSI) by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Diagnostic Centres
- 2.4.3 Hospitals
- 2.4.4 Research & Academic Centres
- 2.4.5 Pharmaceutical & Biotechnology Companies
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Medical Hyperspectral Imaging (MHSI) Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Medical Hyperspectral Imaging (MHSI) Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Medical Hyperspectral Imaging (MHSI) Revenue of Manufacturers (2021-2026)
- 3.4 Global Medical Hyperspectral Imaging (MHSI) Average Price by Manufacturers (2021-2026)
- 3.5 Global Medical Hyperspectral Imaging (MHSI) Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Medical Hyperspectral Imaging (MHSI), Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Medical Hyperspectral Imaging (MHSI), Product Type & Application
- 3.8 Global Manufacturers of Medical Hyperspectral Imaging (MHSI), Established Date
- 3.9 Global Medical Hyperspectral Imaging (MHSI) Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Headwall Photonics
- 4.1.1 Headwall Photonics Company Information
- 4.1.2 Headwall Photonics Business Overview
- 4.1.3 Headwall Photonics Medical Hyperspectral Imaging (MHSI) Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Headwall Photonics Medical Hyperspectral Imaging (MHSI) Product Portfolio
- 4.1.5 Headwall Photonics Recent Developments
- 4.2 Resonon
- 4.2.1 Resonon Company Information
- 4.2.2 Resonon Business Overview
- 4.2.3 Resonon Medical Hyperspectral Imaging (MHSI) Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Resonon Medical Hyperspectral Imaging (MHSI) Product Portfolio
- 4.2.5 Resonon Recent Developments
- 4.3 IMEC
- 4.3.1 IMEC Company Information
- 4.3.2 IMEC Business Overview
- 4.3.3 IMEC Medical Hyperspectral Imaging (MHSI) Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 IMEC Medical Hyperspectral Imaging (MHSI) Product Portfolio
- 4.3.5 IMEC Recent Developments
- 4.4 EVK DI Kerschhaggl
- 4.4.1 EVK DI Kerschhaggl Company Information
- 4.4.2 EVK DI Kerschhaggl Business Overview
- 4.4.3 EVK DI Kerschhaggl Medical Hyperspectral Imaging (MHSI) Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 EVK DI Kerschhaggl Medical Hyperspectral Imaging (MHSI) Product Portfolio
- 4.4.5 EVK DI Kerschhaggl Recent Developments
- 4.5 Cubert
- 4.5.1 Cubert Company Information
- 4.5.2 Cubert Business Overview
- 4.5.3 Cubert Medical Hyperspectral Imaging (MHSI) Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Cubert Medical Hyperspectral Imaging (MHSI) Product Portfolio
- 4.5.5 Cubert Recent Developments
- 4.6 Galileo
- 4.6.1 Galileo Company Information
- 4.6.2 Galileo Business Overview
- 4.6.3 Galileo Medical Hyperspectral Imaging (MHSI) Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Galileo Medical Hyperspectral Imaging (MHSI) Product Portfolio
- 4.6.5 Galileo Recent Developments
- 4.7 Specim
- 4.7.1 Specim Company Information
- 4.7.2 Specim Business Overview
- 4.7.3 Specim Medical Hyperspectral Imaging (MHSI) Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Specim Medical Hyperspectral Imaging (MHSI) Product Portfolio
- 4.7.5 Specim Recent Developments
- 4.8 Gooch & Housego
- 4.8.1 Gooch & Housego Company Information
- 4.8.2 Gooch & Housego Business Overview
- 4.8.3 Gooch & Housego Medical Hyperspectral Imaging (MHSI) Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Gooch & Housego Medical Hyperspectral Imaging (MHSI) Product Portfolio
- 4.8.5 Gooch & Housego Recent Developments
- 4.9 Surface Optics
- 4.9.1 Surface Optics Company Information
- 4.9.2 Surface Optics Business Overview
- 4.9.3 Surface Optics Medical Hyperspectral Imaging (MHSI) Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Surface Optics Medical Hyperspectral Imaging (MHSI) Product Portfolio
- 4.9.5 Surface Optics Recent Developments
- 4.10 Norsk Elektro Optikk A/S
- 4.10.1 Norsk Elektro Optikk A/S Company Information
- 4.10.2 Norsk Elektro Optikk A/S Business Overview
- 4.10.3 Norsk Elektro Optikk A/S Medical Hyperspectral Imaging (MHSI) Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Norsk Elektro Optikk A/S Medical Hyperspectral Imaging (MHSI) Product Portfolio
- 4.10.5 Norsk Elektro Optikk A/S Recent Developments
- 4.11 Wayho Technology
- 4.11.1 Wayho Technology Company Information
- 4.11.2 Wayho Technology Business Overview
- 4.11.3 Wayho Technology Medical Hyperspectral Imaging (MHSI) Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Wayho Technology Medical Hyperspectral Imaging (MHSI) Product Portfolio
- 4.11.5 Wayho Technology Recent Developments
- 4.12 BaySpec
- 4.12.1 BaySpec Company Information
- 4.12.2 BaySpec Business Overview
- 4.12.3 BaySpec Medical Hyperspectral Imaging (MHSI) Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 BaySpec Medical Hyperspectral Imaging (MHSI) Product Portfolio
- 4.12.5 BaySpec Recent Developments
5 Global Medical Hyperspectral Imaging (MHSI) Market Scenario by Region
- 5.1 Global Medical Hyperspectral Imaging (MHSI) Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Medical Hyperspectral Imaging (MHSI) Sales by Region: 2021-2032
- 5.2.1 Global Medical Hyperspectral Imaging (MHSI) Sales by Region: 2021-2026
- 5.2.2 Global Medical Hyperspectral Imaging (MHSI) Sales by Region: 2027-2032
- 5.3 Global Medical Hyperspectral Imaging (MHSI) Revenue by Region: 2021-2032
- 5.3.1 Global Medical Hyperspectral Imaging (MHSI) Revenue by Region: 2021-2026
- 5.3.2 Global Medical Hyperspectral Imaging (MHSI) Revenue by Region: 2027-2032
- 5.4 North America Medical Hyperspectral Imaging (MHSI) Market Facts & Figures by Country
- 5.4.1 North America Medical Hyperspectral Imaging (MHSI) Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Medical Hyperspectral Imaging (MHSI) Sales by Country (2021-2032)
- 5.4.3 North America Medical Hyperspectral Imaging (MHSI) Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Medical Hyperspectral Imaging (MHSI) Market Facts & Figures by Country
- 5.5.1 Europe Medical Hyperspectral Imaging (MHSI) Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Medical Hyperspectral Imaging (MHSI) Sales by Country (2021-2032)
- 5.5.3 Europe Medical Hyperspectral Imaging (MHSI) Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Medical Hyperspectral Imaging (MHSI) Market Facts & Figures by Country
- 5.6.1 Asia Pacific Medical Hyperspectral Imaging (MHSI) Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Medical Hyperspectral Imaging (MHSI) Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Medical Hyperspectral Imaging (MHSI) Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Medical Hyperspectral Imaging (MHSI) Market Facts & Figures by Country
- 5.7.1 South America Medical Hyperspectral Imaging (MHSI) Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Medical Hyperspectral Imaging (MHSI) Sales by Country (2021-2032)
- 5.7.3 South America Medical Hyperspectral Imaging (MHSI) Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Medical Hyperspectral Imaging (MHSI) Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Medical Hyperspectral Imaging (MHSI) Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Medical Hyperspectral Imaging (MHSI) Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Medical Hyperspectral Imaging (MHSI) Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Medical Hyperspectral Imaging (MHSI) Sales by Type (2021-2032)
- 6.1.1 Global Medical Hyperspectral Imaging (MHSI) Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Medical Hyperspectral Imaging (MHSI) Sales Market Share by Type (2021-2032)
- 6.2 Global Medical Hyperspectral Imaging (MHSI) Revenue by Type (2021-2032)
- 6.2.1 Global Medical Hyperspectral Imaging (MHSI) Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Medical Hyperspectral Imaging (MHSI) Revenue Market Share by Type (2021-2032)
- 6.3 Global Medical Hyperspectral Imaging (MHSI) Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Medical Hyperspectral Imaging (MHSI) Sales by Application (2021-2032)
- 7.1.1 Global Medical Hyperspectral Imaging (MHSI) Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Medical Hyperspectral Imaging (MHSI) Sales Market Share by Application (2021-2032)
- 7.2 Global Medical Hyperspectral Imaging (MHSI) Revenue by Application (2021-2032)
- 7.2.1 Global Medical Hyperspectral Imaging (MHSI) Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Medical Hyperspectral Imaging (MHSI) Revenue Market Share by Application (2021-2032)
- 7.3 Global Medical Hyperspectral Imaging (MHSI) Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Medical Hyperspectral Imaging (MHSI) Value Chain Analysis
- 8.1.1 Medical Hyperspectral Imaging (MHSI) Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Medical Hyperspectral Imaging (MHSI) Production Mode & Process
- 8.2 Medical Hyperspectral Imaging (MHSI) Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Medical Hyperspectral Imaging (MHSI) Distributors
- 8.2.3 Medical Hyperspectral Imaging (MHSI) Customers
9 Global Medical Hyperspectral Imaging (MHSI) Analyzing Market Dynamics
- 9.1 Medical Hyperspectral Imaging (MHSI) Industry Trends
- 9.2 Medical Hyperspectral Imaging (MHSI) Industry Drivers
- 9.3 Medical Hyperspectral Imaging (MHSI) Industry Opportunities and Challenges
- 9.4 Medical Hyperspectral Imaging (MHSI) Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst